Tilray Brands Inc (TLRY)
1.98
-0.14
(-6.60%)
USD |
NASDAQ |
May 17, 16:00
1.97
-0.01
(-0.51%)
After-Hours: 05:27
Tilray Brands Enterprise Value: 1.796B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.796B |
| May 16, 2024 | 1.912B |
| May 15, 2024 | 1.857B |
| May 14, 2024 | 1.874B |
| May 13, 2024 | 1.766B |
| May 10, 2024 | 1.717B |
| May 09, 2024 | 1.757B |
| May 08, 2024 | 1.733B |
| May 07, 2024 | 1.757B |
| May 06, 2024 | 1.814B |
| May 03, 2024 | 1.854B |
| May 02, 2024 | 1.790B |
| May 01, 2024 | 1.790B |
| April 30, 2024 | 2.153B |
| April 29, 2024 | 1.531B |
| April 26, 2024 | 1.539B |
| April 25, 2024 | 1.516B |
| April 24, 2024 | 1.586B |
| April 23, 2024 | 1.586B |
| April 22, 2024 | 1.493B |
| April 19, 2024 | 1.500B |
| April 18, 2024 | 1.493B |
| April 17, 2024 | 1.493B |
| April 16, 2024 | 1.578B |
| April 15, 2024 | 1.539B |
| Date | Value |
|---|---|
| April 12, 2024 | 1.570B |
| April 11, 2024 | 1.632B |
| April 10, 2024 | 1.725B |
| April 09, 2024 | 1.752B |
| April 08, 2024 | 2.166B |
| April 05, 2024 | 2.170B |
| April 04, 2024 | 2.236B |
| April 03, 2024 | 2.367B |
| April 02, 2024 | 2.027B |
| April 01, 2024 | 2.042B |
| March 28, 2024 | 2.073B |
| March 27, 2024 | 2.081B |
| March 26, 2024 | 1.949B |
| March 25, 2024 | 1.825B |
| March 22, 2024 | 1.949B |
| March 21, 2024 | 1.671B |
| March 20, 2024 | 1.694B |
| March 19, 2024 | 1.647B |
| March 18, 2024 | 1.647B |
| March 15, 2024 | 1.500B |
| March 14, 2024 | 1.400B |
| March 13, 2024 | 1.454B |
| March 12, 2024 | 1.462B |
| March 11, 2024 | 1.454B |
| March 08, 2024 | 1.477B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
562.09M
Minimum
Mar 18 2020
9.965B
Maximum
Jun 09 2021
2.683B
Average
1.841B
Median
Sep 22 2022
Enterprise Value Benchmarks
| Clever Leaves Holdings Inc | -0.3486M |
| Flora Growth Corp | 11.58M |
| Acasti Pharma Inc | 0.1704M |
| Aurinia Pharmaceuticals Inc | 473.30M |
| Edesa Biotech Inc | 11.83M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -92.70M |
| Revenue (Quarterly) | 188.34M |
| Total Expenses (Quarterly) | 221.71M |
| EPS Diluted (Quarterly) | -0.12 |
| Gross Profit Margin (Quarterly) | 26.23% |
| Profit Margin (Quarterly) | -49.22% |
| Earnings Yield | -22.22% |
| Normalized Earnings Yield | -26.59 |